The purpose of the current study was to gain a better understanding of the behavior of rucaparib by delineating the mechanism of its vasoactivity using rat arterial tissue and tumor-recruited vascular tissue in wild-type and PARP-1-/- mice. Here, PARP1 is linked to neoplasm.